Bessemer Group Inc Genmab A/S Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Genmab A/S stock. As of the latest transaction made, Bessemer Group Inc holds 126 shares of GMAB stock, worth $2,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126

Holding current value

$2,594

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.84 - $28.48 $3,003 - $3,588	126 New	126 $3,000
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $4,649 - $5,599	-185 Closed	0 $0
Q1 2024 May 13, 2024	BUY	$26.43 - $32.77 $4,889 - $6,062	185 New	185 $6,000
Q2 2023 Aug 10, 2023	SELL	$37.4 - $42.94 $710 - $815	-19 Reduced 7.06%	250 $10,000
Q1 2023 May 10, 2023	BUY	$34.88 - $43.22 $7,464 - $9,249	214 Added 389.09%	269 $10,000
Q4 2022 Feb 13, 2023	SELL	$33.8 - $47.06 $5,374 - $7,482	-159 Reduced 74.3%	55 $2,000
Q3 2022 Nov 09, 2022	BUY	$31.52 - $373.61 $6,745 - $79,952	214 New	214 $7,000
Q2 2022 Aug 10, 2022	SELL	$26.83 - $38.57 $18,324 - $26,343	-683 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$30.95 - $39.68 $14,639 - $18,768	-473 Reduced 40.92%	683 $25,000
Q4 2021 Jan 27, 2022	BUY	$35.87 - $47.12 $13,881 - $18,235	387 Added 50.33%	1,156 $46,000
Q2 2021 Aug 06, 2021	SELL	$32.88 - $44.57 $31,236 - $42,341	-950 Reduced 55.26%	769 $31,000
Q1 2021 May 13, 2021	BUY	$30.92 - $44.4 $53,151 - $76,323	1,719 New	1,719 $56,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account